Department of Cardiology, Changhai Hospital, Shanghai, China.
Department of Physiology, Ningxia Medical University, Yinchuan, China.
Cell Biol Int. 2022 Mar;46(3):475-487. doi: 10.1002/cbin.11753. Epub 2022 Jan 12.
Mutations of PSEN1 have been reported in dilated cardiomyopathy pedigrees. Understanding the effects and mechanisms of PSEN1 in cardiomyocytes might have important implications for treatment of heart diseases. Here, we showed that PSEN1 was downregulated in ischemia-induced failing hearts. Functionally, cardiovascular specific PSEN1 deletion led to spontaneous death of the mice due to cardiomyopathy. At the age of 11 months, the ratio of the heart weight/body weight was slightly lower in the Sm22a-PSEN1-KO mice compared with that of the WT mice. Echocardiography showed that the percentage of ejection fraction and fractional shortening was significantly reduced in the Sm22a-PSEN1-KO group compared with the percent of these measures in the WT group, indicating that PSEN1-KO resulted in heart failure. The abnormally regulated genes resulted from PSEN1-KO were detected to be enriched in muscle development and dilated cardiomyopathy. Among them, several genes encode Ca ion channels, promoting us to investigate the effects of PSEN1 KO on regulation of Ca in isolated adult cardiomyocytes. Consistently, in isolated adult cardiomyocytes, PSEN1-KO increased the concentration of cytosolic Ca and reduced Ca concentration inside the sarcoplasmic reticulum (SR) lumen at the resting stage. Additionally, SR Ca was decreased in the failing hearts of WT mice, but with the lowest levels observed in the failing hearts of PSEN1 knockout mice. These results indicate that the process of Ca release from SR into cytoplasm was affected by PSEN1 KO. Therefore, the abnormalities in Ca homeostasis resulted from downregulation of PSEN1 in failing hearts might contribute to aging-related cardiomyopathy, which might had important implications for the treatment of aging-related heart diseases.
PSEN1 的突变已在扩张型心肌病家系中报道。了解 PSEN1 在心肌细胞中的作用和机制可能对心脏病的治疗具有重要意义。在这里,我们表明 PSEN1 在缺血诱导的衰竭心脏中下调。功能上,心血管特异性 PSEN1 缺失导致由于心肌病导致小鼠自发性死亡。在 11 个月大时,与 WT 小鼠相比,Sm22a-PSEN1-KO 小鼠的心脏重量/体重比略低。超声心动图显示,Sm22a-PSEN1-KO 组的射血分数和缩短分数百分比明显低于 WT 组的这些测量值,表明 PSEN1-KO 导致心力衰竭。PSEN1-KO 导致的异常调节基因被检测到富集在肌肉发育和扩张型心肌病中。其中,一些基因编码 Ca 离子通道,促使我们研究 PSEN1-KO 对分离成年心肌细胞中 Ca 调节的影响。一致地,在分离的成年心肌细胞中,PSEN1-KO 增加了胞质 Ca 浓度,并在静息状态下降低了肌浆网 (SR) 腔内部的 Ca 浓度。此外,WT 小鼠衰竭心脏中的 SR Ca 减少,但 PSEN1 敲除小鼠衰竭心脏中的 SR Ca 减少幅度最大。这些结果表明,PSEN1-KO 影响了从 SR 到细胞质的 Ca 释放过程。因此,衰竭心脏中 PSEN1 下调导致的 Ca 稳态异常可能导致与衰老相关的心肌病,这可能对与衰老相关的心脏病的治疗具有重要意义。